The 'kiss of death' by dendritic cells to cancer cells (Q36975757)

17 August 2017

1 reference

title

The 'kiss of death' by dendritic cells to cancer cells (English)

1 reference

17 August 2017

1 reference

Chan CW

1

1 reference

17 August 2017

Housseau F

series ordinal

2

1 reference

17 August 2017

publication date

19 October 2007

1 reference

Cell Death & Differentiation

17 August 2017

published in

1 reference

17 August 2017

volume

15

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

58-69

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Cell death modalities: classification and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Delivering the kiss of death: progress on understanding how perforin works

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Cytotoxic T lymphocytes: all roads lead to death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

TRAIL: a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Targeting death receptors in cancer with Apo2L/TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Malignancy after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Natural-killer cells and dendritic cells: "l'union fait la force".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Differential antigen processing by dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Is cancer dangerous to the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Immune tolerance after delivery of dying cells to dendritic cells in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The induction of tolerance by dendritic cells that have captured apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Natural killer cells and dendritic cells: rendezvous in abused tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Tumoricidal activity of monocyte-derived dendritic cells: evidence for a caspase-8-dependent, Fas-associated death domain-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

A subset of cytolytic dendritic cells in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Natural killer or dendritic: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

21 January 2018

DC-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

TRAIL and apoptosis induction by TNF-family death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Mutation analysis and mRNA expression of trail-receptors in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

TRAIL resistance results in cancer progression: a TRAIL to perdition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Combined Stimulation with Interleukin-18 and CpG Induces Murine Natural Killer Dendritic Cells to Produce IFN-γ and Inhibit Tumor Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

Tumor-host immune interactions and dendritic cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Immune response against dying tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Neutrophils efficiently cross-prime naive T cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Clearance of apoptotic cells by phagocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4402235

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4402235

1 reference

17 August 2017

1 reference